Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.44 |
| ▸ | KCNA4 | P22459 | 1/20 | 0.43 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.43 |
| ▸ | KCNAB1 | Q14722 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 7/20 | 0.38 |
| ▸ | MAOA | P21397 | 6/20 | 0.38 |
| ▸ | MAOB | P27338 | 6/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1333408 | 0.91 | SOAT1 (0.46) | MEN1CYP2C19KMT2AALDH1A1SOAT1 | |
| SCHEMBL744431 | 0.90 | MEN1 (0.62) | MEN1CYP2C19KMT2AALDH1A1SOAT1 | |
| SCHEMBL10158721 | 0.83 | MEN1 (0.58) | MEN1CYP2C19KMT2AALDH1A1KCNA4 | |
| SCHEMBL10085150 | 0.82 | MEN1 (0.53) | MEN1CYP2C19KMT2AALDH1A1SOAT1 | |
| SCHEMBL1333747 | 0.81 | MAPK1 (0.41) | MEN1CYP2C19KMT2AALDH1A1SOAT1 | |
| SCHEMBL13352408 | 0.81 | MEN1 (0.60) | MEN1CYP2C19KMT2AALDH1A1SOAT1 | |
| SCHEMBL1301510 | 0.80 | MEN1 (0.50) | MEN1CYP2C19KMT2AALDH1A1SOAT1 | |
| SCHEMBL14491585 | 0.80 | MEN1 (0.47) | MEN1CYP2C19KMT2AALDH1A1KCNA4 | |
| SCHEMBL14070596 | 0.80 | MEN1 (0.50) | MEN1CYP2C19KMT2AALDH1A1SOAT1 | |
| SCHEMBL9876533 | 0.77 | MEN1 (0.60) | MEN1CYP2C19KMT2AALDH1A1SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7416867-B2 | Enzymatic production of (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-26 | — | — | US | claimed |
| EP-1599594-B1 | ENZYMATIC PRODUCTION OF (METH)ACRYLIC ACID ESTERS | BASF AG (DE) | 2007-05-30 | — | — | EP | claimed |
| US-20060141593-A1 | Enzymatic production of (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-29 | — | — | US | claimed |
| JP-60099181-A | — | — | None | — | — | JP | disclosed |
| US-8859787-B2 | Glycol compound having dioxane structure and method for producing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-20110269976-A1 | GLYCOL COMPOUND HAVING DIOXANE STRUCTURE AND METHOD FOR PRODUCING THE SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2011-11-03 | — | — | US | disclosed |
| US-7416867-B2 | Enzymatic production of (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-26 | — | — | US | disclosed |
| EP-1599594-B1 | ENZYMATIC PRODUCTION OF (METH)ACRYLIC ACID ESTERS | BASF AG (DE) | 2007-05-30 | — | — | EP | disclosed |
| US-20060141593-A1 | Enzymatic production of (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-29 | — | — | US | disclosed |
| EP-1599594-A1 | ENZYMATIC PRODUCTION OF (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004076676-A1 | ENZYMATIC PRODUCTION OF (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-10 | — | — | WO | disclosed |
| EP-0247472-B1 | PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID DERIVATIVES | BAYER AG (DE) | 1992-02-12 | — | — | EP | disclosed |
| EP-0247472-A2 | Process for the preparation of carboxylic acid derivatives | BAYER AG (DE) | 1987-12-02 | — | — | EP | disclosed |
| JP-S6099181-A | CURABLE COMPOSITION | TOAGOSEI CHEM IND CO LTD | 1985-06-03 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269976-A1 | GLYCOL COMPOUND HAVING DIOXANE STRUCTURE AND METHOD FOR PRODUCING THE SAME | RXRA, RARA, RXRG | MEN1 3191/4885CYP2C19 1857/4885KMT2A 2737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.